Skip to content
Research Article Open access CC BY 4.0

Investigating the Roles of Gut Microbiome in the Progression of Neurodegenerative Diseases: Alzheimer's, Parkinson's, and Amyotrophic Lateral Sclerosis (ALS)

Emmanson Emmanson Godswill, Ogunwale Fawas Abiodun, Chiamaka Mercy Ogboji, Ojo Oluwakemi Janet, Anthonia. B. O, Sunday Kaura, Augustine Chibuike Olunwa, Godswill Obidike

International Neuropsychiatric Disease Journal · pp. 26–44 · Published 6 Apr 2024

10.9734/indj/2024/v21i3433

Abstract

Neurodegenerative diseases (NDs), such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Amyotrophic Lateral Sclerosis (ALS), pose global health burdens due to their incurable and degenerative nature. Emerging evidence highlights the complex interplay between the gut microbiome and the central nervous system (CNS), revealing novel mechanisms of ND pathogenesis and progression. This review integrates current literature, correlation analyses, and inferential statistics to elucidate the impact of gut microbiome dysbiosis on NDs and identify potential diagnostic biomarkers and therapeutic targets. The gut-brain axis (GBA), a bidirectional communication network between the gut and the brain, modulates neurological function and disease outcomes. Correlation analyses demonstrated significant associations between gut microbiome perturbations and ND parameters, implying a causal role for gut dysbiosis in ND pathogenesis. Inferential statistics revealed distinct microbial profiles between ND cohorts and healthy controls, indicating a shared gut dysbiosis across diverse NDs. Studies investigating microbial taxa, metabolites, and signaling pathways have provided insights into the molecular mechanisms underlying gut microbiome-mediated effects on neurodegeneration. Elucidating the reciprocal interactions between the gut microbiome and the host physiology is essential for deciphering the GBA’s role in NDs. Despite advances, knowledge gaps remain. Longitudinal studies are required to monitor gut microbiome dynamics over ND progression. Mechanistic studies are needed to establish how gut microbiome composition affects disease. Methodological standardization for gut microbiome assessment is imperative for rigorous research. Future endeavors should aim to translate findings into clinical applications to exploit microbiome-based interventions for enhanced neurological outcomes in NDs.

Neurodegenerative diseases alzheimer's disease parkinson's disease amyotrophic lateral sclerosis Gut microbiome gut-brain axis dysbiosis cognitive decline motor deficits neuroinflammation therapeutic interventions

References (14)

  1. 1 Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour [DOI]
  2. 2 Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease [DOI]
  3. 3 Gut microbiome alterations in Alzheimer’s disease [DOI]
  4. 4 Gut microbiota are related to Parkinson's disease and clinical phenotype [DOI]
  5. 5 The role of gut microbiota in immune homeostasis and autoimmunity [DOI]
  6. 6 Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly [DOI]
  7. 7 Control of Brain Development, Function, and Behavior by the Microbiome [DOI]
  8. 8 Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota [DOI]
  9. 9 Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome [DOI]
  10. 10 The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease [DOI]
  11. 11 Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels [DOI]
  12. 12 Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease [DOI]
  13. 13 The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored [DOI]
  14. 14 International Journal of Molecular Sciences [DOI]

Cited by 3

Gut–Brain Axis and Bile Acid Signaling: Linking Microbial Metabolism to Brain Function and Metabolic Regulation

Bojan Stanimirov, Maja Đanić, Nebojša Pavlović · International Journal of Molecular Sciences · 2025

Futuristic therapeutics in pipeline for the betterment of neurodegenerative disorders

Harshit Upadhyay, Pritisha Das, Sanskriti · Elsevier eBooks · 2025

Showing 2 of 3 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

27

Page views

0

PDF downloads

3

Outbound clicks

3

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.